Etude : Roscovitine
Type d'étude : Modulateur du CFTR
Titre : A Phase II, Dose Ranging, Multicenter, Double-blind, Placebo Controlled Study to Evaluate Safety and Effects of (R)-Roscovitine in Adults Subjects With Cystic Fibrosis, Carrying 2 Cystic Fibrosis Causing Mutations With at Least One F508del-CFTR Mutation and Chronically Infected With Pseudomonas Aeruginosa, a Study Involving 36 CF Patients (24 Treated, 12 Controls). ROSCO-CF.
Phase : 2
Promoteurs :
Study in France
Age : 18 Years and Older
Lien internet : https://clinicaltrials.gov/ct2/show/NCT02649751
Type d'étude : Modulateur du CFTR
Titre : A Phase II, Dose Ranging, Multicenter, Double-blind, Placebo Controlled Study to Evaluate Safety and Effects of (R)-Roscovitine in Adults Subjects With Cystic Fibrosis, Carrying 2 Cystic Fibrosis Causing Mutations With at Least One F508del-CFTR Mutation and Chronically Infected With Pseudomonas Aeruginosa, a Study Involving 36 CF Patients (24 Treated, 12 Controls). ROSCO-CF.
Phase : 2
Promoteurs :
Study in France
Age : 18 Years and Older
Lien internet : https://clinicaltrials.gov/ct2/show/NCT02649751